Cargando…

The Effects of CD73 on Gastrointestinal Cancer Progression and Treatment

Gastrointestinal (GI) cancer is a common and deadly malignant tumor. CD73, a cell-surface protein, acts as a switch of the adenosine-related signaling pathway that can cause significant immunosuppression. Recent evidence has emerged that CD73 is a promising immunotherapy target for regaining immune...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Pengcheng, Zheng, Xiao, Li, Xiaodong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130010/ https://www.ncbi.nlm.nih.gov/pubmed/35620732 http://dx.doi.org/10.1155/2022/4330329

Ejemplares similares

CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers
por: Harvey, Jerry B., et al.
Publicado: (2020)

The Roles of CD73 in Cancer
por: Gao, Zhao-wei, et al.
Publicado: (2014)

The distinct role of CD73 in the progression of pancreatic cancer
por: Zhou, Liangjing, et al.
Publicado: (2019)

The Clinical Significance of CD73 in Cancer
por: Bach, Niklas, et al.
Publicado: (2023)

CD39/CD73/A2AR pathway and cancer immunotherapy
por: Xia, Chenglai, et al.
Publicado: (2023)

CD73, Tumor Plasticity and Immune Evasion in Solid Cancers
por: Yang, Haitang, et al.
Publicado: (2021)

CD73: Friend or Foe in Lung Injury
por: Hu, Xiu-Min, et al.
Publicado: (2023)

Research progress on GP73 in malignant tumors
por: Liang, Rong, et al.
Publicado: (2018)

Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR
por: Ploeg, Emily Maria, et al.
Publicado: (2023)

CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid Carcinoma
por: Jeong, Young Mun, et al.
Publicado: (2020)

CD73 Promotes Tumor Progression in Patients with Esophageal Squamous Cell Carcinoma
por: Chen, Yen-Hao, et al.
Publicado: (2021)

Physiological roles for ecto-5’-nucleotidase (CD73)
por: Colgan, Sean P., et al.
Publicado: (2006)

CD73 promotes colitis-associated tumorigenesis in mice
por: Liu, Xuan-Hui, et al.
Publicado: (2020)

CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer
por: Petruk, Nataliia, et al.
Publicado: (2021)

CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancer
por: Chen, Qiangda, et al.
Publicado: (2020)

The ectonucleotidases CD39 and CD73 on T cells: The new pillar of hematological malignancy
por: Jiang, Xuan, et al.
Publicado: (2023)

The double-edge sword effect of anti-CD73 cancer therapy
por: Stagg, John
Publicado: (2012)

CD73: A Promising Biomarker in Cancer Patients
por: Turiello, Roberta, et al.
Publicado: (2020)

Exploring CD39 and CD73 Expression as Potential Biomarkers in Prostate Cancer
por: Gardani, Carla Fernanda Furtado, et al.
Publicado: (2023)

Roles of the Adenosine Receptor and CD73 in the Regulatory Effect of γδ T Cells
por: Liang, Dongchun, et al.
Publicado: (2014)

CD73-Generated Adenosine: Orchestrating the Tumor-Stroma Interplay to Promote Cancer Growth
por: Allard, Bertrand, et al.
Publicado: (2012)

CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73
Publicado: (1995)

DNA Methylation Activates TP73 Expression in Hepatocellular Carcinoma and Gastrointestinal Cancer
por: Yao, Zhixing, et al.
Publicado: (2019)

CD73 is associated with poor prognosis in HNSCC
por: Ren, Zhen-Hu, et al.
Publicado: (2016)

Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73(-) Phenotype Identifies Polyfunctional Cytotoxic Lymphocytes
por: Ahmadi, Parimah, et al.
Publicado: (2020)

The CD73/Ado System—A New Player in RT Induced Adverse Late Effects
por: de Leve, Simone, et al.
Publicado: (2019)

Antitumor effect of combined NAMPT and CD73 inhibition in an ovarian cancer model
por: Sociali, Giovanna, et al.
Publicado: (2015)

CD73, a significant protein in liver diseases
por: Shi, Huilian, et al.
Publicado: (2023)

Detection of CD39 and a Highly Glycosylated Isoform of Soluble CD73 in the Plasma of Patients with Cervical Cancer: Correlation with Disease Progression
por: Muñóz-Godínez, Ricardo, et al.
Publicado: (2020)

CD73 Promotes Chronic Lymphocytic Leukemia
por: Allard, David, et al.
Publicado: (2022)

A role for EMT in CD73 regulation in breast cancer
por: Hasmim, Meriem, et al.
Publicado: (2022)

CD73 downregulation by EGFR-targeted liposomal CD73 siRNA potentiates antitumor effect of liposomal doxorubicin in 4T1 tumor-bearing mice
por: Soleimani, Anvar, et al.
Publicado: (2022)

Diverging prognostic effects of CD155 and CD73 expressions in locally advanced triple-negative breast cancer
por: Cabioglu, Neslihan, et al.
Publicado: (2023)

Prospective isolation of human fibroadipogenic progenitors with CD73
por: Goloviznina, Natalya A., et al.
Publicado: (2020)

Research progress of ginseng in the treatment of gastrointestinal cancers
por: Ni, Baoyi, et al.
Publicado: (2022)

Downregulation of CD73 associates with T cell exhaustion in AML patients
por: Kong, Yaxian, et al.
Publicado: (2019)

A Novel Anti-CD73 Antibody That Selectively Inhibits Membrane CD73 Shows Antitumor Activity and Induces Tumor Immune Escape
por: Kellner, Markus, et al.
Publicado: (2022)

CD73 Is Critical for the Resolution of Murine Colonic Inflammation
por: Bynoe, Margaret S., et al.
Publicado: (2012)

CD73 Expressed on γδ T Cells Shapes Their Regulatory Effect in Experimental Autoimmune Uveitis
por: Liang, Dongchun, et al.
Publicado: (2016)

Prediction of cancer progression in a group of 73 gastric cancer patients by circulating cell-free DNA
por: Pu, Wang-Yang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uuuj0ognfqvutiapgq99ro42lt